144 related articles for article (PubMed ID: 38402205)
1. Activation-induced cytidine deaminase causes recurrent splicing mutations in diffuse large B-cell lymphoma.
Benitez-Cantos MS; Cano C; Cuadros M; Medina PP
Mol Cancer; 2024 Feb; 23(1):42. PubMed ID: 38402205
[TBL] [Abstract][Full Text] [Related]
2. MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation.
Deutsch AJ; Aigelsreiter A; Staber PB; Beham A; Linkesch W; Guelly C; Brezinschek RI; Fruhwirth M; Emberger W; Buettner M; Beham-Schmid C; Neumeister P
Blood; 2007 Apr; 109(8):3500-4. PubMed ID: 17197434
[TBL] [Abstract][Full Text] [Related]
3. Recurrent targets of aberrant somatic hypermutation in lymphoma.
Khodabakhshi AH; Morin RD; Fejes AP; Mungall AJ; Mungall KL; Bolger-Munro M; Johnson NA; Connors JM; Gascoyne RD; Marra MA; Birol I; Jones SJ
Oncotarget; 2012 Nov; 3(11):1308-19. PubMed ID: 23131835
[TBL] [Abstract][Full Text] [Related]
4. Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma.
Bödör C; Bognár A; Reiniger L; Szepesi A; Tóth E; Kopper L; Matolcsy A
Br J Haematol; 2005 May; 129(3):373-6. PubMed ID: 15842661
[TBL] [Abstract][Full Text] [Related]
5. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
6. AID and TET2 co-operation modulates FANCA expression by active demethylation in diffuse large B cell lymphoma.
Jiao J; Jin Y; Zheng M; Zhang H; Yuan M; Lv Z; Odhiambo W; Yu X; Zhang P; Li C; Ma Y; Ji Y
Clin Exp Immunol; 2019 Feb; 195(2):190-201. PubMed ID: 30357811
[TBL] [Abstract][Full Text] [Related]
7. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
[TBL] [Abstract][Full Text] [Related]
8. AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma.
Gu X; Booth CJ; Liu Z; Strout MP
Blood; 2016 Jan; 127(1):102-12. PubMed ID: 26385350
[TBL] [Abstract][Full Text] [Related]
9. Frequent expression of activation-induced cytidine deaminase in diffuse large B-cell lymphoma tissues from persons living with HIV.
Shponka V; Reveles CY; Alam S; Jaramillo M; Maguire A; Rimsza LM; Kendrick S
AIDS; 2020 Nov; 34(14):2025-2035. PubMed ID: 32773475
[TBL] [Abstract][Full Text] [Related]
10. Expression of activation-induced cytidine deaminase is associated with a poor prognosis of diffuse large B cell lymphoma patients treated with CHOP-based chemotherapy.
Kawamura K; Wada A; Wang JY; Li Q; Ishii A; Tsujimura H; Takagi T; Itami M; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
J Cancer Res Clin Oncol; 2016 Jan; 142(1):27-36. PubMed ID: 26077666
[TBL] [Abstract][Full Text] [Related]
11. Expression of the AID protein in normal and neoplastic B cells.
Pasqualucci L; Guglielmino R; Houldsworth J; Mohr J; Aoufouchi S; Polakiewicz R; Chaganti RS; Dalla-Favera R
Blood; 2004 Nov; 104(10):3318-25. PubMed ID: 15304391
[TBL] [Abstract][Full Text] [Related]
12. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.
Lohr JG; Stojanov P; Lawrence MS; Auclair D; Chapuy B; Sougnez C; Cruz-Gordillo P; Knoechel B; Asmann YW; Slager SL; Novak AJ; Dogan A; Ansell SM; Link BK; Zou L; Gould J; Saksena G; Stransky N; Rangel-Escareño C; Fernandez-Lopez JC; Hidalgo-Miranda A; Melendez-Zajgla J; Hernández-Lemus E; Schwarz-Cruz y Celis A; Imaz-Rosshandler I; Ojesina AI; Jung J; Pedamallu CS; Lander ES; Habermann TM; Cerhan JR; Shipp MA; Getz G; Golub TR
Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3879-84. PubMed ID: 22343534
[TBL] [Abstract][Full Text] [Related]
13. AID assists DNMT1 to attenuate BCL6 expression through DNA methylation in diffuse large B-cell lymphoma cell lines.
Jiao J; Lv Z; Zhang P; Wang Y; Yuan M; Yu X; Otieno Odhiambo W; Zheng M; Zhang H; Ma Y; Ji Y
Neoplasia; 2020 Mar; 22(3):142-153. PubMed ID: 32062068
[TBL] [Abstract][Full Text] [Related]
14. Intraclonal diversity in follicular lymphoma analyzed by quantitative ultradeep sequencing of noncoding regions.
Spence JM; Abumoussa A; Spence JP; Burack WR
J Immunol; 2014 Nov; 193(10):4888-94. PubMed ID: 25311808
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide mutational signatures revealed distinct developmental paths for human B cell lymphomas.
Ye X; Ren W; Liu D; Li X; Li W; Wang X; Meng FL; Yeap LS; Hou Y; Zhu S; Casellas R; Zhang H; Wu K; Pan-Hammarström Q
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33136155
[TBL] [Abstract][Full Text] [Related]
16. A Hyper-IgM Syndrome Mutation in Activation-Induced Cytidine Deaminase Disrupts G-Quadruplex Binding and Genome-wide Chromatin Localization.
Yewdell WT; Kim Y; Chowdhury P; Lau CM; Smolkin RM; Belcheva KT; Fernandez KC; Cols M; Yen WF; Vaidyanathan B; Angeletti D; McDermott AB; Yewdell JW; Sun JC; Chaudhuri J
Immunity; 2020 Nov; 53(5):952-970.e11. PubMed ID: 33098766
[TBL] [Abstract][Full Text] [Related]
17. Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network.
Crouch S; Painter D; Barrans SL; Roman E; Beer PA; Cooke SL; Glover P; Van Hoppe SJL; Webster N; Lacy SE; Ruiz C; Campbell PJ; Hodson DJ; Patmore R; Burton C; Smith A; Tooze RM
Blood Adv; 2022 Nov; 6(21):5716-5731. PubMed ID: 35363872
[TBL] [Abstract][Full Text] [Related]
18. Activation-induced cytidine deaminase displays an alternative co-factor for modulating PIM1 expression in diffuse large B cell lymphoma cell lines.
Wang Y; Miao Y; Zhou W; Bi Y; Ji Y; Ma Y
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):1-7. PubMed ID: 37300695
[TBL] [Abstract][Full Text] [Related]
19. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.
Lossos IS; Levy R; Alizadeh AA
Leukemia; 2004 Nov; 18(11):1775-9. PubMed ID: 15385936
[TBL] [Abstract][Full Text] [Related]
20. Aberrant somatic hypermutations in thyroid lymphomas.
Takakuwa T; Miyauchi A; Aozasa K
Leuk Res; 2009 May; 33(5):649-54. PubMed ID: 19019431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
